taliglucerase alfa
Selected indexed studies
- Taliglucerase alfa. (, 2006) [PMID:30000979]
- Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease. (Orphanet J Rare Dis, 2018) [PMID:29471850]
- Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. (Mol Genet Metab, 2014) [PMID:24630271]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Taliglucerase alfa. (2006) pubmed
- Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease. (2018) pubmed
- Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. (2014) pubmed
- Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease. (2017) pubmed
- Taliglucerase alfa in the longterm treatment of children and adolescents with type 1 Gaucher disease: the Albanian experience. (2024) pubmed
- Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience. (2018) pubmed
- Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS). (2022) pubmed
- Open-label, expanded access study of taliglucerase alfa in patients with Gaucher disease requiring enzyme replacement therapy. (2020) pubmed
- Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study. (2023) pubmed
- Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase. (2016) pubmed